author-photo

Margaret Green

Royal Surrey County Hospital

17

Papers

831

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer

2019 Oncotarget
Show All
- Source
- Cite
- Save
Citations (10)
The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (15)
Abstract 5014: Predictive value of wild-type EGFR determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients

2006 International Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (46)
Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer

2005 International Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (59)
The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters.

2004 International Journal of Oncology
Show All
- Source
- Cite
- Save
Citations (31)
Pattern of metastasis within sentinel nodes predicts non-sentinel lymph node involvement – do all patients with a positive sentinel node biopsy need a lymph node clearance?

2004 Melanoma Research
Show All
- Source
- Cite
- Save
Citations (1)
The Microanatomic Location of Metastatic Melanoma in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (242)
Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62

2003 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Targeting of cells expressing wild‐type EGFR and type‐III mutant EGFR (EGFRvIII) by anti‐EGFR MAb ICR62: A two‐pronged attack for tumour therapy

2003 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (52)